Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion

NCT00166894 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2005-11-24

No results posted yet for this study

Summary

The aim of this trial is to evaluate the level of TREM-1 in different kinds of pleural effusion.

Conditions

  • Pleural Effusion

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Pan-Chyr Yang, MD, PhD · Department of International Medicine, National Taiwan University Hospital

Eligibility

Min Age
18 Minutes
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00166894 on ClinicalTrials.gov